T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| 1 |
UnitedHealth
UNH
|
$865M |
| 2 |
AbbVie
ABBV
|
$688M |
| 3 |
Intuit
INTU
|
$574M |
| 4 |
Xcel Energy
XEL
|
$466M |
| 5 |
Exelon
EXC
|
$432M |
Top Sells
| 1 |
GE Aerospace
GE
|
$1.37B |
| 2 |
TE Connectivity
TEL
|
$629M |
| 3 |
Equifax
EFX
|
$338M |
| 4 |
KLA
KLAC
|
$321M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
$299M |
Sector Composition
| 1 | Technology | 24.86% |
| 2 | Healthcare | 22.76% |
| 3 | Financials | 12.37% |
| 4 | Consumer Discretionary | 11.76% |
| 5 | Industrials | 11.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Palomar
PLMR
$3.3B
| $67.4M | 0.05% |
1,221,497
+22,175
| +2% | +$1.22M |
|
|
PMT
327
PennyMac Mortgage Investment
PMT
$1.08B
| $65.6M | 0.05% |
5,316,369
+628,133
| +13% | +$7.74M |
|
328
DigitalBridge
DBRG
$2.05B
| $65.4M | 0.05% |
5,456,617
-297,427
| -5% | -$3.57M |
|
329
Wyndham Hotels & Resorts
WH
$6.57B
| $65.3M | 0.05% |
962,562
+47,769
| +5% | +$3.24M |
|
330
Leidos
LDOS
$22.8B
| $65M | 0.05% |
706,059
-819,845
| -54% | -$75.5M |
|
331
Visteon
VC
$3.35B
| $64.7M | 0.05% |
412,854
-51,140
| -11% | -$8.02M |
|
332
Agilon Health
AGL
$497M
| $63.8M | 0.05% |
2,684,480
-51,700
| -2% | -$1.23M |
|
333
FTI Consulting
FCN
$5.43B
| $63.4M | 0.05% |
321,220
-34,797
| -10% | -$6.87M |
|
334
Pacific Biosciences
PACB
$378M
| $62.8M | 0.05% |
5,420,563
-649,976
| -11% | -$7.53M |
|
|
TXNM
335
TXNM Energy, Inc.
TXNM
$5.97B
| $62.2M | 0.04% |
1,278,656
+10,564
| +0.8% | +$514K |
|
336
Green Dot
GDOT
$760M
| $62.2M | 0.04% |
3,619,461
+685,304
| +23% | +$11.8M |
|
337
First American
FAF
$6.63B
| $61.8M | 0.04% |
1,110,025
+6,175
| +0.6% | +$344K |
|
338
Outset Medical
OM
$245M
| $60.6M | 0.04% |
3,294,148
-225,722
| -6% | -$4.15M |
|
|
CFB
339
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $60.1M | 0.04% |
5,731,830
+1,087,856
| +23% | +$11.4M |
|
340
Myers Industries
MYE
$613M
| $59.8M | 0.04% |
2,791,771
-488,312
| -15% | -$10.5M |
|
341
LCI Industries
LCII
$2.5B
| $59.7M | 0.04% |
543,129
+34,287
| +7% | +$3.77M |
|
342
Dime Community Bancshares
DCOM
$1.33B
| $59.6M | 0.04% |
2,624,052
-170,832
| -6% | -$3.88M |
|
343
Pennant Group
PNTG
$853M
| $59.3M | 0.04% |
4,151,919
+41,753
| +1% | +$596K |
|
344
Kymera Therapeutics
KYMR
$3.1B
| $58.3M | 0.04% |
1,968,175
+12,198
| +0.6% | +$361K |
|
345
Preferred Bank
PFBC
$1.17B
| $57.5M | 0.04% |
1,049,637
+6,822
| +0.7% | +$374K |
|
346
10x Genomics
TXG
$1.66B
| $57.2M | 0.04% |
+1,025,961
| New | +$57.2M |
|
347
Encore Capital Group
ECPG
$958M
| $56.2M | 0.04% |
1,114,657
+72,651
| +7% | +$3.67M |
|
|
IBTX
348
DELISTED
Independent Bank Group, Inc.
IBTX
| $56M | 0.04% |
1,209,182
-159,678
| -12% | -$7.4M |
|
349
Boston Omaha
BOC
$425M
| $56M | 0.04% |
2,367,440
-402,464
| -15% | -$9.53M |
|
350
Asbury Automotive
ABG
$4.99B
| $56M | 0.04% |
+266,589
| New | +$56M |
|